• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者开始使用干扰素β-1b治疗时的治疗期望:与治疗依从性的关系

Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment.

作者信息

Mohr D C, Goodkin D E, Likosky W, Gatto N, Neilley L K, Griffin C, Stiebling B

机构信息

University of California, San Francisco, USA.

出版信息

Mult Scler. 1996 Dec;2(5):222-6. doi: 10.1177/135245859600200502.

DOI:10.1177/135245859600200502
PMID:9050360
Abstract

This study, conducted in three separate outpatient health care delivery settings, examined the therapeutic expectations of patients with multiple sclerosis (MS) before they initiated interferon beta-1b therapy, the results of current educational procedures to correct unrealistic expectations, and the relationship between post-education expectations and discontinuing therapy. Ninety-nine consecutive patients were seen in a university based outpatient MS clinic, an academic group practice outpatient MS clinic, or a health maintenance organization outpatient neurology clinic. Before the educational sessions, 57% of the patients expressed unrealistically optimistic expectations regarding reduction in attack rate and 34% expressed unrealistically optimistic expectations regarding improvement in functional status. Educational procedures significantly altered unrealistic expectations but the results were sub-optimal since 33% of the patients maintained overly optimistic expectations regarding reduction in attack rate. Post-education unrealistic expectations of improvement in functional status were significantly related to discontinuing therapy within 6 months. Three adverse effects of therapy also were related independently to adherence to treatment: depression and flu-like symptoms were related to discontinuing therapy while soreness at injection site was related to continuing therapy.

摘要

本研究在三个独立的门诊医疗服务机构中开展,调查了多发性硬化症(MS)患者在开始使用β-1b干扰素治疗前的治疗期望、当前纠正不切实际期望的教育措施的效果,以及教育后期望与停止治疗之间的关系。连续99名患者分别就诊于一所大学附属医院的门诊MS诊所、一个学术团体执业门诊MS诊所或一个健康维护组织门诊神经科诊所。在开展教育课程之前,57%的患者对发作率降低表达了不切实际的乐观期望,34%的患者对功能状态改善表达了不切实际的乐观期望。教育措施显著改变了不切实际的期望,但效果并不理想,因为33%的患者对发作率降低仍保持过度乐观的期望。教育后对功能状态改善的不切实际期望与6个月内停止治疗显著相关。治疗的三种不良反应也与坚持治疗独立相关:抑郁和流感样症状与停止治疗有关,而注射部位疼痛与继续治疗有关。

相似文献

1
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment.多发性硬化症患者开始使用干扰素β-1b治疗时的治疗期望:与治疗依从性的关系
Mult Scler. 1996 Dec;2(5):222-6. doi: 10.1177/135245859600200502.
2
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.抑郁症的治疗可提高多发性硬化症患者对β-1b干扰素治疗的依从性。
Arch Neurol. 1997 May;54(5):531-3. doi: 10.1001/archneur.1997.00550170015009.
3
Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.一名多发性硬化症患者在接受β-干扰素治疗期间发生重症肌无力。
Neurology. 1997 Dec;49(6):1747-8. doi: 10.1212/wnl.49.6.1747-a.
4
[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects].[用β-1b干扰素治疗多发性硬化症。对患者进行教育及处理副作用]
Nervenarzt. 1996 Jun;67(6):452-6.
5
Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.使用β-1b干扰素治疗多发性硬化症。患者因渴望战胜疾病而愿意忍受副作用。
BMJ. 1996 Nov 16;313(7067):1263. doi: 10.1136/bmj.313.7067.1263.
6
Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.中和抗体与干扰素β-1b在复发缓解型多发性硬化症中的疗效
Mult Scler. 1997 Dec;3(6):402. doi: 10.1177/135245859700300610.
7
Nursing management of MS patients receiving interferon beta-1b therapy.
Rehabil Nurs. 1997 Mar-Apr;22(2):62-6, 81. doi: 10.1002/j.2048-7940.1997.tb01735.x.
8
Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.β-干扰素1b在多发性硬化症中的应用。制造商为该药物辩护。
BMJ. 1996 Nov 16;313(7067):1263. doi: 10.1136/bmj.313.7067.1263a.
9
Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.β-1b干扰素在多发性硬化症中的应用。复发的重要性不可低估。
BMJ. 1996 Nov 16;313(7067):1263. doi: 10.1136/bmj.313.7067.1263b.
10
Treatment of multiple sclerosis with interferon beta-1 b.用β-1b干扰素治疗多发性硬化症。
Neurology. 1997 Aug;49(2):641-2. doi: 10.1212/wnl.49.2.641.

引用本文的文献

1
Treatment Adherence in MS: Does Objective MS Knowledge and MS Risk Knowledge Matter in Relation to Perceived Disease-Modifying Therapy Benefits?多发性硬化症的治疗依从性:客观的多发性硬化症知识和多发性硬化症风险知识与感知到的疾病修正疗法益处相关吗?
Neurol Ther. 2025 Aug 13. doi: 10.1007/s40120-025-00806-x.
2
Switching from injectable to other Disease Modifying Therapies may improve sexual dysfunction in people with Multiple Sclerosis.从注射用药物改为其他疾病修正疗法可能会改善多发性硬化症患者的性功能障碍。
BMC Neurol. 2024 Jul 24;24(1):255. doi: 10.1186/s12883-024-03765-2.
3
PHREND-A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis.
PHREND——一种基于真实世界数据的工具,支持临床决策以优化复发缓解型多发性硬化症的治疗。
Front Digit Health. 2022 Mar 11;4:856829. doi: 10.3389/fdgth.2022.856829. eCollection 2022.
4
Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.一项评估者设盲、活性对照、随机对照试验,旨在比较针对新诊断多发性硬化症患者的个体化认知行为疗法与支持性倾听干预对抑郁症的疗效(ACTION-MS 试验):方案。
Trials. 2020 Jan 20;21(1):100. doi: 10.1186/s13063-019-4018-8.
5
A Novel Tool to Improve Shared Decision Making and Adherence in Multiple Sclerosis: Development and Preliminary Testing.一种改善多发性硬化症共同决策与依从性的新型工具:开发与初步测试
MDM Policy Pract. 2019 Oct 16;4(2):2381468319879134. doi: 10.1177/2381468319879134. eCollection 2019 Jul-Dec.
6
Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany.德国多发性硬化症专科中心的患者满意度与医疗服务
Ther Adv Neurol Disord. 2018 Jan 23;11:1756285617748845. doi: 10.1177/1756285617748845. eCollection 2018.
7
Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis.与多发性硬化症患者对疾病修正治疗偏好相关的因素。
J Manag Care Spec Pharm. 2017 Aug;23(8):822-830. doi: 10.18553/jmcp.2017.23.8.822.
8
Treatment discontinuation in multiple sclerosis: The French Web-based survey ALLIANCE.多发性硬化症的治疗中断:基于网络的法国ALLIANCE调查。
Mult Scler J Exp Transl Clin. 2015 Aug 19;1:2055217315600720. doi: 10.1177/2055217315600720. eCollection 2015 Jan-Dec.
9
A new graphical format to communicate treatment effects to patients-A web-based randomized controlled trial.一种向患者传达治疗效果的新图形格式——基于网络的随机对照试验。
Health Expect. 2017 Aug;20(4):797-804. doi: 10.1111/hex.12522. Epub 2016 Dec 16.
10
A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis.一项针对新诊断为多发性硬化症患者的抑郁症状,基于量身定制的认知行为疗法干预措施的试点随机对照试验。
BMC Psychiatry. 2016 Dec 7;16(1):435. doi: 10.1186/s12888-016-1152-7.